{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:19:24Z","timestamp":1761974364157},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>We present a case of posterior reversible encephalopathy syndrome (PRES) in a pediatric patient with Burkitt's lymphoma predominantly involving the bone marrow. <jats:sup>18<\/jats:sup>F-FDG PET\/CT scan obtained after the first cycle of chemotherapy, complicated by acute kidney injury, hypertension, tumor lysis syndrome, and lethargy with focal neurological symptoms, showed a favorable marrow and lymph node response but increased FDG uptake in the bilateral frontal and occipital cortical\/subcortical regions. Brain MRI was consistent with PRES. The patient was managed with IV hydration and blood pressure control with symptom resolution. This case shows the <jats:sup>18<\/jats:sup>F-FDG uptake pattern of PRES in postchemotherapy setting.<\/jats:p>","DOI":"10.1097\/rlu.0000000000001979","type":"journal-article","created":{"date-parts":[[2018,1,21]],"date-time":"2018-01-21T02:06:01Z","timestamp":1516500361000},"page":"195-198","source":"Crossref","is-referenced-by-count":7,"title":["Posterior Reversible Encephalopathy Syndrome on 18F-FDG PET\/CT in a Pediatric Patient With Burkitt\u2019s Lymphoma"],"prefix":"10.1097","volume":"43","author":[{"given":"Ehab","family":"Saad Aldin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parren","family":"McNeely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuf","family":"Menda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20231021","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4103\/1817-1745.102579","article-title":"Posterior reversible encephalopathy syndrome and the pediatric population","volume":"7","year":"2012","journal-title":"J Pediatr Neurosci"},{"key":"bib2-20231021","doi-asserted-by":"crossref","first-page":"468.e1","DOI":"10.1016\/j.ajog.2013.02.015","article-title":"Posterior reversible encephalopathy syndrome in 46 of 47 patients with eclampsia","volume":"208","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"bib3-20231021","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s00247-005-1434-6","article-title":"The role of tumor lysis in reversible posterior leukoencephalopathy syndrome","volume":"35","year":"2005","journal-title":"Pediatr Radiol"},{"key":"bib4-20231021","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199602223340803","article-title":"A reversible posterior leukoencephalopathy syndrome","volume":"334","year":"1996","journal-title":"N Engl J Med"},{"key":"bib5-20231021","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10072-006-0667-y","article-title":"PRES: posterior or potentially reversible encephalopathy syndrome?","volume":"27","year":"2006","journal-title":"Neurol Sci"},{"key":"bib6-20231021","first-page":"2179","article-title":"Posterior reversible encephalopathy syndrome in infection, sepsis, and shock","volume":"27","year":"2006","journal-title":"AJNR Am J Neuroradiol"},{"key":"bib7-20231021","first-page":"CR549","article-title":"Clinical spectrum and critical care management of Posterior Reversible Encephalopathy Syndrome (PRES)","volume":"11","year":"2005","journal-title":"Med Sci Monit"},{"key":"bib8-20231021","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1016\/j.clml.2014.01.005","article-title":"Posterior reversible encephalopathy syndrome (PRES) complicating newly-diagnosed diffuse large B-cell lymphoma","volume":"14","year":"2014","journal-title":"Clin Lymphoma Myeloma Leuk"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003072-201803000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T04:07:25Z","timestamp":1697861245000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201803000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000001979","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]}}}